Citations (26)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Eiji Kirino. (2012) Escitalopram for the management of major depressive disorder: a review of its efficacy, safety, and patient acceptability. Patient Preference and Adherence 6, pages 853-861.
Read now
Read now
Hatta Sidi, Duni Asmidar, Rozita Hod, Nik Ruzyanei Nik Jaafar & Ng Chong Guan. (2012) Hypoactive sexual desire among depressed female patients treated with selective serotonin reuptake inhibitors: A comparison between escitalopram and fluoxetine. International Journal of Psychiatry in Clinical Practice 16:1, pages 41-47.
Read now
Read now
Jana Strohmaier, Stefan Wüst, Rudolf Uher, Neven Henigsberg, Ole Mors, Joanna Hauser, Daniel Souery, Astrid Zobel, Mojca Z. Dernovsek, Fabian Streit, Christine Schmäl, Dejan Kozel, Anna Placentino, Anne Farmer, Peter McGuffin, Katherine J. Aitchison & Marcella Rietschel. (2011) Sexual dysfunction during treatment with serotonergic and noradrenergic antidepressants: Clinical description and the role of the 5-HTTLPR. The World Journal of Biological Psychiatry 12:7, pages 528-538.
Read now
Read now
Michael E Thase. (2006) Managing depressive and anxiety disorders with escitalopram. Expert Opinion on Pharmacotherapy 7:4, pages 429-440.
Read now
Read now
Articles from other publishers (22)
Vishal Bhatia, Ashwani K. Dhingra, Bhawna Chopra & Kumar Guarve. (2023) A Review of Clinical Studies Assessing the Therapeutic Efficacy of
Escitalopram: A Step Towards Development. CNS & Neurological Disorders - Drug Targets 22:1, pages 41-50.
Crossref
Crossref
Marissa J. Luft, Eric T. Dobson, Amir Levine, Paul E. Croarkin & Jeffrey R. Strawn. (2021) Pharmacologic interventions for antidepressant-induced sexual dysfunction: a systematic review and network meta-analysis of trials using the Arizona sexual experience scale. CNS Spectrums, pages 1-10.
Crossref
Crossref
Brunella V. González Cautela, Gonzalo R. Quintana, Jessica Akerman & James G. Pfaus. (2020) Acute caffeine reverses the disruptive effects of chronic fluoxetine on the sexual behavior of female and male rats.. Psychopharmacology 238:3, pages 755-764.
Crossref
Crossref
Robert E. Pyke & Anita H. Clayton. (2019) Lumping, Splitting, and Treating: Therapies Are Needed for Women With Overlapping Sexual Dysfunctions. Sexual Medicine Reviews 7:4, pages 551-558.
Crossref
Crossref
Christina M. Dording & Sean D. Boyden. 2019. The Massachusetts General Hospital Guide to Depression. The Massachusetts General Hospital Guide to Depression
123
137
.
Carmita Helena Najjar Abdo. 2018. Sexual Dysfunctions in Mentally Ill Patients. Sexual Dysfunctions in Mentally Ill Patients
225
249
.
Anita H. Clayton, Andrew R. Alkis, Nishant B. Parikh & Jennifer G. Votta. (2016) Sexual Dysfunction Due to Psychotropic Medications. Psychiatric Clinics of North America 39:3, pages 427-463.
Crossref
Crossref
Eiji Kirino. 2016. Melatonin, Neuroprotective Agents and Antidepressant Therapy. Melatonin, Neuroprotective Agents and Antidepressant Therapy
465
476
.
Toshiaki Kikuchi, Takefumi Suzuki, Hiroyuki Uchida, Koichiro Watanabe & Masaru Mimura. (2013) Association between antidepressant side effects and functional impairment in patients with major depressive disorders. Psychiatry Research 210:1, pages 127-133.
Crossref
Crossref
Margaret D. Eugenio, Sang-Eun Jun, Kevin C. Cain, Monica E. Jarrett & Margaret M. Heitkemper. (2012) Comprehensive Self-Management Reduces the Negative Impact of Irritable Bowel Syndrome Symptoms on Sexual Functioning. Digestive Diseases and Sciences 57:6, pages 1636-1646.
Crossref
Crossref
Hatta Sidi, Duni Asmidar, Rozita Hod & Ng Chong Guan. (2012) Female Sexual Dysfunction in Patients Treated with Antidepressant—Comparison Between Escitalopram and Fluoxetine. The Journal of Sexual Medicine 9:5, pages 1392-1399.
Crossref
Crossref
Susan D. Reed, Katherine A. Guthrie, Hadine Joffe, Jan L. Shifren, Rebecca A. Seguin & Ellen W. Freeman. (2012) Sexual Function in Nondepressed Women Using Escitalopram for Vasomotor Symptoms. Obstetrics & Gynecology 119:3, pages 527-538.
Crossref
Crossref
Michael A. Perelman. (2011) Erectile Dysfunction and Depression: Screening and Treatment. Urologic Clinics of North America 38:2, pages 125-139.
Crossref
Crossref
Toshiaki Kikuchi, Hiroyuki Uchida, Takefumi Suzuki, Koichiro Watanabe & Haruo Kashima. (2010) Patients’ attitudes toward side effects of antidepressants: an Internet survey. European Archives of Psychiatry and Clinical Neuroscience 261:2, pages 103-109.
Crossref
Crossref
Karly P. Garnock-Jones & Paul L. McCormack. (2010) Escitalopram. CNS Drugs 24:9, pages 769-796.
Crossref
Crossref
John Kelly. 2010. Principles of CNS Drug Development. Principles of CNS Drug Development
173
210
.
Ilan Rabinowitz, Yehuda Baruch & Yoram Barak. (2008) High-dose escitalopram for the treatment of obsessive–compulsive disorder. International Clinical Psychopharmacology 23:1, pages 49-53.
Crossref
Crossref
P. Van Dijck. (2007) Escitalopram, un développement clinique complet. L'Encéphale 33, pages 134-139.
Crossref
Crossref
Antoine Makhlouf, Ashay Kparker & Craig S. Niederberger. (2007) Depression and Erectile Dysfunction. Urologic Clinics of North America 34:4, pages 565-574.
Crossref
Crossref
Sharon Rosenzweig-Lipson, Chad E. Beyer, Zoë A. Hughes, Xavier Khawaja, Somana J. Rajarao, Jessica E. Malberg, Zia Rahman, Robert H. Ring & Lee E. Schechter. (2007) Differentiating antidepressants of the future: Efficacy and safety. Pharmacology & Therapeutics 113:1, pages 134-153.
Crossref
Crossref
. (2005) Current awareness: Pharmacoepidemiology and drug safety. Pharmacoepidemiology and Drug Safety 14:11, pages i-xii.
Crossref
Crossref
David Murdoch & Susan J Keam. (2005) Escitalopram. Drugs 65:16, pages 2379-2404.
Crossref
Crossref